GSI Technology Announces Participation in 8th Annual LD

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
91
GSI Technology Announces Participation in 8th Annual LD Micro Invitational

SUNNYVALE, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (NASDAQ: GSIT ), a leading provider of high performance semiconductor memory solutions, today announced that Douglas Schirle, Chief Financial Officer and Didier Lasserre, Vice President of Sales, will participate in the 8th Annual LD Micro Invitational on Tuesday, June 5, 2018. Management will present at 11:30 am Pacific Time and will be available for one-on-one meetings the same day.

The Company’s group presentation will be available for the public to access at http://wsw.com/webcast/ldmicro14/gsit /. This webcast will be archived for 90 days following the live presentation.

The 8th Annual LD Micro Invitational will be held June 4-6, 2018 at the Luxe Sunset Hotel in Bel-Air, California located at 11461 Sunset Boulevard. For more information, or to schedule a one-on-one meeting the Company, please contact David Scher at david@ldmicro.com or call (831) 566-6995.

About LD Micro LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. We are investors, first and foremost. What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually (Invitational, Summit, and Main Event). In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday information on the entire sector, including the first pure microcap index (LDMi) which covers stocks in North America with market capitalizations between $50-$300m.

About GSI Technology  Founded in 1995, GSI Technology, Inc. is a provider of high performance semiconductor memory solutions to networking, industrial, medical, aerospace and military customers. The company is headquartered in Sunnyvale, California and has sales offices in the Americas, Europe and Asia. For more information, please visit  www.gsitechnology.com .

Contacts:

Investor Relations Hayden IR Kim Rogers 385-831-7337

Company: GSI Technology, Inc. Douglas M. Schirle Chief Financial Officer 408-331-9802

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading